- Home
- FDMT vs RPID Comparison
FDMT vs RPID Comparison
Compare FDMT & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FDMT
- RPID
- Stock Information
- Founded
- FDMT 2013
- RPID 2006
- Country
- FDMT United States
- RPID United States
- Employees
- FDMT N/A
- RPID N/A
- Industry
- FDMT Biotechnology: Pharmaceutical Preparations
- RPID Medical Specialities
- Sector
- FDMT Health Care
- RPID Health Care
- Exchange
- FDMT Nasdaq
- RPID Nasdaq
- Market Cap
- FDMT 161.7M
- RPID 155.6M
- IPO Year
- FDMT 2020
- RPID 2021
- Fundamental
- Price
- FDMT $3.75
- RPID $3.45
- Analyst Decision
- FDMT Buy
- RPID Buy
- Analyst Count
- FDMT 10
- RPID 1
- Target Price
- FDMT $32.33
- RPID $8.00
- AVG Volume (30 Days)
- FDMT 448.3K
- RPID 159.8K
- Earning Date
- FDMT 05-08-2025
- RPID 05-09-2025
- Dividend Yield
- FDMT N/A
- RPID N/A
- EPS Growth
- FDMT N/A
- RPID N/A
- EPS
- FDMT N/A
- RPID N/A
- Revenue
- FDMT $23,000.00
- RPID $29,645,000.00
- Revenue This Year
- FDMT $13,097.30
- RPID $18.54
- Revenue Next Year
- FDMT N/A
- RPID $20.55
- P/E Ratio
- FDMT N/A
- RPID N/A
- Revenue Growth
- FDMT N/A
- RPID 28.36
- 52 Week Low
- FDMT $2.24
- RPID $0.58
- 52 Week High
- FDMT $28.93
- RPID $4.04
- Technical
- Relative Strength Index (RSI)
- FDMT 57.33
- RPID 64.18
- Support Level
- FDMT $3.37
- RPID $3.15
- Resistance Level
- FDMT $3.81
- RPID $3.84
- Average True Range (ATR)
- FDMT 0.27
- RPID 0.26
- MACD
- FDMT 0.03
- RPID 0.02
- Stochastic Oscillator
- FDMT 82.02
- RPID 60.20
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.
About RPID Rapid Micro Biosystems Inc.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.